Gregory M. Glenn
2016
In 2016, Gregory M. Glenn earned a total compensation of $1.6M as President, Research and Development at Novavax, a 12% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,193,920 |
|---|---|
| Salary | $441,250 |
| Other | $7,500 |
| Total | $1,642,670 |
Glenn received $1.2M in option awards, accounting for 73% of the total pay in 2016.
Glenn also received $441.3K in salary and $7.5K in other compensation.
Rankings
In 2016, Gregory M. Glenn's compensation ranked 5,820th out of 14,075 executives tracked by ExecPay. In other words, Glenn earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,820 out of 14,075 | 59th |
Division Manufacturing | 2,112 out of 5,489 | 62nd |
Major group Chemicals And Allied Products | 689 out of 1,895 | 64th |
Industry group Drugs | 518 out of 1,538 | 66th |
Industry Biological Products, Except Diagnostic Substances | 92 out of 279 | 67th |
Source: SEC filing on April 30, 2018.
Glenn's colleagues
We found four more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2016.